title: Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.
abstract: The Nomenclature Committee of the International Society of Amyloidosis (ISA) met during the XVth Symposium of the Society, 3 July-7 July 2016, Uppsala, Sweden, to assess and formulate recommendations for nomenclature for amyloid fibril proteins and the clinical classification of the amyloidoses. An amyloid fibril must exhibit affinity for Congo red and with green, yellow or orange birefringence when the Congo red-stained deposits are viewed with polarized light. While congophilia and birefringence remain the gold standard for demonstration of amyloid deposits, new staining and imaging techniques are proving useful. To be included in the nomenclature list, in addition to congophilia and birefringence, the chemical identity of the protein must be unambiguously characterized by protein sequence analysis when possible. In general, it is insufficient to identify a mutation in the gene of a candidate amyloid protein without confirming the variant changes in the amyloid fibril protein. Each distinct form of amyloidosis is uniquely characterized by the chemical identity of the amyloid fibril protein that deposits in the extracellular spaces of tissues and organs and gives rise to the disease syndrome. The fibril proteins are designated as protein A followed by a suffix that is an abbreviation of the parent or precursor protein name. To date, there are 36 known extracellular fibril proteins in humans, 2 of which are iatrogenic in nature and 9 of which have also been identified in animals. Two newly recognized fibril proteins, AApoCII derived from apolipoprotein CII and AApoCIII derived from apolipoprotein CIII, have been added. AApoCII amyloidosis and AApoCIII amyloidosis are hereditary systemic amyloidoses. Intracellular protein inclusions displaying some of the properties of amyloid, "intracellular amyloid" have been reported. Two proteins which were previously characterized as intracellular inclusions, tau and α-synuclein, are now recognized to form extracellular deposits upon cell death and thus have been included in Table 1 as ATau and AαSyn.
authors.affiliation: a Department of Biochemistry (Retired) , Boston University School of Medicine , Boston , MA , USA.
authors.forename: Jean D
authors.initials: JD
authors.lastname: Sipe
authors.affiliation: b Department of Pathology and Laboratory Medicine , Indiana University School of Medicine , Indianapolis , IN , USA.
authors.forename: Merrill D
authors.initials: MD
authors.lastname: Benson
authors.affiliation: c Department of Molecular and Experimental Medicine , The Scripps Research Institute , La Jolla , CA , USA.
authors.forename: Joel N
authors.initials: JN
authors.lastname: Buxbaum
authors.affiliation: d Department of Medicine (Neurology and Rheumatology) , Shinshu University School of Medicine , Matsumoto , Japan.
authors.forename: Shu-Ichi
authors.initials: SI
authors.lastname: Ikeda
authors.affiliation: e Amyloid Research and Treatment Center, University of Pavia and IRCCS Policlinico San Matteo , Pavia , Italy.
authors.forename: Giampaolo
authors.initials: G
authors.lastname: Merlini
authors.affiliation: f Amyloid Unit, Institute of Molecular and Cellular Biology, University of Porto , Porto , Portugal , and.
authors.forename: Maria J M
authors.initials: MJ
authors.lastname: Saraiva
authors.affiliation: g Department of Immunology , Genetics and Pathology, Uppsala University , Uppsala , Sweden.
authors.forename: Per
authors.initials: P
authors.lastname: Westermark
mesh_terms: D058227:Amyloidogenic Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D000686:Amyloidosis / Q000145:classification / Q000175:diagnosis* / Q000235:genetics* / Q000473:pathology; D053304:Apolipoprotein C-II / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D053305:Apolipoprotein C-III / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D001718:Birefringence; D004396:Coloring Agents / Q000737:chemistry; D003224:Congo Red / Q000737:chemistry; D015870:Gene Expression; D017408:Guidelines as Topic; D006801:Humans; D011228:Prealbumin / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D011498:Protein Precursors / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D020539:Sequence Analysis, Protein; D013194:Staining and Labeling / Q000379:methods; D009626:Terminology as Topic; D051844:alpha-Synuclein / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D016875:tau Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism
chemical_list: D058227:Amyloidogenic Proteins; D053304:Apolipoprotein C-II; D053305:Apolipoprotein C-III; D015415:Biomarkers; D004396:Coloring Agents; D011228:Prealbumin; D011498:Protein Precursors; D051844:alpha-Synuclein; D016875:tau Proteins; D003224:Congo Red
keywords: Amyloid fibril; amyloid protein; amyloidosis; inclusion body; nomenclature